BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7651743)

  • 1. p53 dependent growth suppression by the c-Abl nuclear tyrosine kinase.
    Goga A; Liu X; Hambuch TM; Senechal K; Major E; Berk AJ; Witte ON; Sawyers CL
    Oncogene; 1995 Aug; 11(4):791-9. PubMed ID: 7651743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Abl tyrosine kinase can mediate tumor cell apoptosis independently of the Rb and p53 tumor suppressors.
    Theis S; Roemer K
    Oncogene; 1998 Aug; 17(5):557-64. PubMed ID: 9704921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RB-resistant Abl kinase induces delayed cell cycle progression and increases susceptibility to apoptosis upon cellular stresses through interaction with p53.
    Cho JW; Chung J; Baek WK; Suh SI; Kwon TK; Park JW; Suh MH
    Int J Oncol; 2003 Jun; 22(6):1193-9. PubMed ID: 12738983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of c-abl facilitates anchorage-independent growth of p53- and RB- deficient primary mouse embryonic fibroblasts.
    Suzuki J; Sukezane T; Akagi T; Georgescu MM; Ohtani M; Inoue H; Jat PS; Goff SP; Hanafusa H; Shishido T
    Oncogene; 2004 Nov; 23(52):8527-34. PubMed ID: 15378021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of v-Abl transformation by p53 and p19ARF.
    Cong F; Zou X; Hinrichs K; Calame K; Goff SP
    Oncogene; 1999 Dec; 18(54):7731-9. PubMed ID: 10618713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-abl is involved in the association of p53 and trk A.
    Brown A; Browes C; Mitchell M; Montano X
    Oncogene; 2000 Jun; 19(26):3032-40. PubMed ID: 10871855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyomavirus large T antigen overcomes p53 dependent growth arrest.
    Doherty J; Freund R
    Oncogene; 1997 Apr; 14(16):1923-31. PubMed ID: 9150359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Abl tyrosine kinase activates p21 transcription via interaction with p53.
    Jing Y; Wang M; Tang W; Qi T; Gu C; Hao S; Zeng X
    J Biochem; 2007 May; 141(5):621-6. PubMed ID: 17339230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle arrest by tyrosine kinase Abl involves altered early mitogenic response.
    Mattioni T; Jackson PK; Bchini-Hooft van Huijsduijnen O; Picard D
    Oncogene; 1995 Apr; 10(7):1325-33. PubMed ID: 7731683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abrogation of retinoblastoma protein function by c-Abl through tyrosine kinase-dependent and -independent mechanisms.
    Welch PJ; Wang JY
    Mol Cell Biol; 1995 Oct; 15(10):5542-51. PubMed ID: 7565706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyamine analogue induction of the p53-p21WAF1/CIP1-Rb pathway and G1 arrest in human melanoma cells.
    Kramer DL; Vujcic S; Diegelman P; Alderfer J; Miller JT; Black JD; Bergeron RJ; Porter CW
    Cancer Res; 1999 Mar; 59(6):1278-86. PubMed ID: 10096560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective loss of endogenous p21waf1/cip1 induction underlies the G1 checkpoint defect of monomeric p53 proteins.
    Tarunina M; Grimaldi M; Ruaro E; Pavlenko M; Schneider C; Jenkins JR
    Oncogene; 1996 Aug; 13(3):589-98. PubMed ID: 8760300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
    Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
    J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of growth arrest by p16INK4, p21WAF1, pRB, and p53 is dependent on the integrity of the endogenous cell-cycle control pathways in human glioblastoma cell lines.
    Costanzi-Strauss E; Strauss BE; Naviaux RK; Haas M
    Exp Cell Res; 1998 Jan; 238(1):51-62. PubMed ID: 9457056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-Abl: activation and nuclear targets.
    Shaul Y
    Cell Death Differ; 2000 Jan; 7(1):10-6. PubMed ID: 10713716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Pezcoller lecture: cancer cell cycles revisited.
    Sherr CJ
    Cancer Res; 2000 Jul; 60(14):3689-95. PubMed ID: 10919634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The retinoblastoma protein is an essential mediator that links the interferon-inducible 204 gene to cell-cycle regulation.
    Hertel L; Rolle S; De Andrea M; Azzimonti B; Osello R; Gribaudo G; Gariglio M; Landolfo S
    Oncogene; 2000 Jul; 19(32):3598-608. PubMed ID: 10951565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of retinoblastoma gene product in p53-mediated DNA damage response.
    Smith ML; Zhan Q; Bae I; Fornace AJ
    Exp Cell Res; 1994 Dec; 215(2):386-9. PubMed ID: 7982477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The alternative reading frame tumor suppressor inhibits growth through p21-dependent and p21-independent pathways.
    Modestou M; Puig-Antich V; Korgaonkar C; Eapen A; Quelle DE
    Cancer Res; 2001 Apr; 61(7):3145-50. PubMed ID: 11306500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.